Literature DB >> 8621225

Male breast cancer in Iceland.

J G Jonasson1, B A Agnarsson, S Thorlacius, J E Eyfjord, H Tulinius.   

Abstract

All malignant tumours of the male breast diagnosed in Iceland during the 40-year period 1955-1994 were studied with regard to histological classification, tumour grading and flow cytometric analysis. Of 31 malignant tumours diagnosed, 29 were primary breast carcinomas. Male breast carcinoma constitutes 1% of all breast malignancies in Iceland and 0.25% of all malignant tumours in males. About 80% of the male breast carcinomas were diagnosed during the latter half of the study period. The mean age of the patients was 66.3 years and the left-to-right ratio was 1.9:1.0. Right-sided tumours appeared to be more aggressive. The mean tumour size was 2.6 cm. The vast majority of the carcinomas (79%) were of the infiltrating ductal type. Of these 21.7% were grade I, 43.5% were grade II and 34.8% grade III. Papillary carcinomas made up 17% of the total. These occurred in slightly older patients than the infiltrating ductal carcinomas and were diploid tumours. In this study 57% of the tumours were found to be aneuploid, but nearly 70% of the invasive ductal carcinomas NOS were aneuploid. In general, the aneuploid tumours were larger, of higher average histological grade and had a higher mean S-phase value. The overall mean S-phase fraction was 7.2% which is similar to that found in female breast tumours in Iceland. It is concluded that male-to-female ratio of breast carcinoma in Iceland is similar to that found in other Western countries. The age-standardised incidence has increased considerably in the last 20 years, in contrast to the rates reported from most other countries. Papillary tumours are unusually common in Icelandic males.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621225     DOI: 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Study of a single BRCA2 mutation with high carrier frequency in a small population.

Authors:  S Thorlacius; S Sigurdsson; H Bjarnadottir; G Olafsdottir; J G Jonasson; L Tryggvadottir; H Tulinius; J E Eyfjörd
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

2.  Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers.

Authors:  Joško Bezić; Ivana Šamija Projić; Petar Projić; Jelena Ljubković; Sandra Zekić Tomaš; Kristina Meljanac Salopek; Marina Piljić Burazer; Snježana Tomić
Journal:  Virchows Arch       Date:  2014-12-04       Impact factor: 4.064

Review 3.  Understanding and management of male breast cancer: a critical review.

Authors:  Kartikeya Pant; Udayan Dutta
Journal:  Med Oncol       Date:  2007-12-12       Impact factor: 3.064

Review 4.  Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.

Authors:  Walid E Khalbuss; Abiy Ambaye; Steve Goodison; Asif Loya; Shahla Masood
Journal:  Diagn Cytopathol       Date:  2006-03       Impact factor: 1.582

5.  CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.

Authors:  K Gudmundsdottir; S Thorlacius; J G Jonasson; B F Sigfusson; L Tryggvadottir; J E Eyfjord
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

6.  Cancer of the breast: 5-year survival in a tertiary hospital in Uganda.

Authors:  A Gakwaya; J B Kigula-Mugambe; A Kavuma; A Luwaga; J Fualal; J Jombwe; M Galukande; D Kanyike
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.